PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Ultrasound patch heals venous ulcers in human trial

New technique could significantly accelerate tissue repair, reduce costs for chronic wound management

2013-08-01
(Press-News.org) In a small clinical study, researchers administered a new method for treating chronic wounds using a novel ultrasound applicator that can be worn like a band-aid. The applicator delivers low-frequency, low-intensity ultrasound directly to wounds, and was found to significantly accelerate healing in five patients with venous ulcers. Venous ulcers are caused when valves in the veins malfunction, causing blood to pool in the leg instead of returning to the heart. This pooling, called venous stasis, can cause proteins and cells in the vein to leak into the surrounding tissue leading to inflammation and formation of an ulcer.

The technology was developed by researchers at Drexel University, Philadelphia, with funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health.

Venous ulcers account for 80 percent of all chronic wounds found on lower extremities and affect approximately 500,000 U.S. patients annually, a number that's expected to increase as obesity rates climb. It's estimated that treatment for venous ulcers costs the U.S. healthcare system over $1 billion dollars per year.

Standard treatment for venous ulcers involves controlling swelling, taking care of the wound by keeping it moist, preventing infection, and compression therapy—a technique in which patients wear elastic socks that squeeze the leg to prevent blood from flowing backwards.

Despite these measures, wounds often take months and occasionally years to heal.

"Right now, we rely mostly on passive treatments," said Michael Weingarten, M.D., chief of vascular surgery at Drexel Medicine and a researcher in the study. "With the exception of expensive skin grafting surgeries, there are very few technologies that actively stimulate healing of these ulcers."

In an article to be published in the Journal of the Acoustical Society of America, the Drexel researchers report that patients who received low-frequency, low-intensity ultrasound treatment during their weekly check-up (in addition to standard compression therapy), showed a net reduction in wound size after just four weeks (Fig. 3a,3b). In contrast, patients who didn't receive ultrasound treatment had an average increase in wound size during the same time period (Fig. 2a,2b).

"There have been studies on the therapeutic benefits of ultrasound for wound healing, but most of the previous research was performed at much higher frequencies, around 1-3 megahertz (MHz)," said Peter A. Lewin, Ph.D., Richard B. Beard Professor of Biomedical Engineering at Drexel, and the primary investigator on this project. "We had an idea that if we went down to the range of 20 to 100 kilohertz (kHz), which is at least an order of magnitude lower, we might see more profound changes; that's exactly what happened."

In order to determine the optimal ultrasound frequency as well as treatment duration, the researchers treated patients with either 15 minutes of 20 kHz ultrasound, 45 minutes of 20 kHz ultrasound, 15 minutes of 100 kHz ultrasound, or 15 minutes of a sham (placebo) ultrasound. The group receiving 15 minutes of 20 kHz ultrasound showed the greatest improvement, with all five patients experiencing complete healing by the fourth treatment.

"We were surprised that the group receiving 45 minutes of treatment didn't achieve the same benefits as the 15 minute group, but sometimes we learn that more is not always better," said Joshua Samuels, a Ph.D. candidate and lead author of the study. "There may be a dosing effect."

The team's clinical findings were corroborated by their in vitro studies in which mouse fibroblasts —cells that play an active role in wound healing—experienced on average a 32 percent increase in cell metabolism and a 40 percent increase in cell proliferation compared with control cells 24 hours after receiving 20 kHz ultrasound for 15 minutes.

Lewin and colleagues said one of the greatest challenges of the study was designing and creating their battery-powered ultrasound patch.

"Most ultrasound transducers require a large apparatus and need to be plugged into the wall. We wanted this to be fully wearable as well as portable, so we needed to make it battery-powered. To achieve that, we had had to design a transducer that could produce medically relevant energy levels using minimum voltage," said Lewin.

Their resulting ultrasound patch weighs just 100 grams—the equivalent of a king sized candy bar—and is connected to two lithium ion batteries which are fully rechargeable. Lewin says the design gives patients the option of using the transducer in a home environment, while still wearing their compression socks. It also prevents the need for a doctor's visit, which can be a difficult task for patients with chronic wounds.

"The wound healing technology described in this study is a particularly exciting ultrasound therapy application that holds great promise for future treatment of chronic wound patients," said Hector Lopez, Ph.D., NIBIB program director for Diagnostic and Therapeutic Ultrasound. "This is an excellent example of how NIBIB brings together the physical and life sciences to produce new technology that improves health." Lopez concluded by saying that before the new treatment would make it to a clinic, studies with larger numbers of patients are needed to confirm that the technology is both effective and safe to use.

In the future, Lewin and Weingarten anticipate that patients with other types of chronic wounds such as diabetic or pressure ulcers may also benefit from therapeutic ultrasound. Because the ideal treatment frequency, duration, and intensity may be unique for each type of wound, Lewin and his colleagues have developed and are currently testing a diagnostic monitoring component of their ultrasound patch, which would help physicians optimize treatment for each patient.

This monitoring component—developed with the help of Leonid Zubkov, D.Sc. of The School of Biomedical Engineering, Science and Health Systems, Drexel—uses near infrared spectroscopy (NIRS) to non-invasively assess changes in the wound bed that can reveal whether a treatment is working in its earliest stages, when healing is difficult to detect with the naked eye.

"By monitoring subtle changes in tissue response as we deliver the ultrasound and immediately after, we can optimize the treatment for each patient," said Lewin. "Our goal is to develop a device that can be used on many different types of wounds for as long as needed without causing side effects. Once we have this universal applicator, we can use the near infrared spectroscopy to help customize the treatment to individual patients."

A trial to test the NIRS component involving twenty patients is currently under way. The team is also hoping to learn more about why low frequency ultrasound promotes healing by expanding their in vitro studies. They are currently examining the effects of low-frequency ultrasound on macrophages—immune cells that play a critical role in wound healing—and on collagen production.

"In wound healing, there is the inflammation phase, the proliferation phase, and the remodeling phase. We're looking at the primary cell participants at each phase and examining the effects of ultrasound on each of these individually and then collectively," said Samuels.

A major contributor to this study was Dr. Elisabeth Papazoglou of the School of Biomedical Engineering, Drexel, who recently passed away.

### NIBIB's mission is to support multidisciplinary research and research training at the crossroads of engineering and the biological and physical sciences. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website: http://www.nibib.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.


ELSE PRESS RELEASES FROM THIS DATE:

New designer compound treats heart failure by targeting cell nucleus

2013-08-01
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure – a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage. In contrast to standard therapies for heart failure, JQ1 works directly within the cell's command center, or nucleus, to prevent damaging stress responses. ...

When galaxies switch off

2013-08-01
Some galaxies hit a point in their lives when their star formation is snuffed out, and they become "quenched". Quenched galaxies in the distant past appear to be much smaller than the quenched galaxies in the Universe today. This has always puzzled astronomers -- how can these galaxies grow if they are no longer forming stars? A team of astronomers has now used a huge set of Hubble observations to give a surprisingly simple answer to this long-standing cosmic riddle. Until now, these small, snuffed-out galaxies were thought to grow into the larger quenched galaxies we ...

Nice organisms finish first: Why cooperators always win in the long run

2013-08-01
Leading physicists last year turned game theory on its head by giving selfish players a sure bet to beat cooperative players. Now two evolutionary biologists at Michigan State University offer new evidence that the selfish will die out in the long run. "We found evolution will punish you if you're selfish and mean," said lead author Christoph Adami, MSU professor of microbiology and molecular genetics. "For a short time and against a specific set of opponents, some selfish organisms may come out ahead. But selfishness isn't evolutionarily sustainable." The paper "Evolutionary ...

Potential nutritional therapy for childhood neurodegenerative disease

2013-08-01
Researchers at the University of California, San Diego School of Medicine have identified the gene mutation responsible for a particularly severe form of pontocerebellar hypoplasia, a currently incurable neurodegenerative disease affecting children. Based on results in cultured cells, they are hopeful that a nutritional supplement may one day be able to prevent or reverse the condition. The study, from a team of international collaborators led by Joseph G. Gleeson, MD – Howard Hughes Medical Institute investigator and professor in the UCSD Departments of Neurosciences ...

A week's worth of camping synchs internal clock to sunrise and sunset, CU-Boulder study finds

2013-08-01
Spending just one week exposed only to natural light while camping in the Rocky Mountains was enough to synch the circadian clocks of eight people participating in a University of Colorado Boulder study with the timing of sunrise and sunset. The study, published online today in the journal Current Biology, found that the synchronization happened in that short period of time for all participants, regardless of whether they were early birds or night owls during their normal lives. "What's remarkable is how, when we're exposed to natural sunlight, our clocks perfectly ...

Stray prenatal gene network suspected in schizophrenia

2013-08-01
Researchers have reverse-engineered the outlines of a disrupted prenatal gene network in schizophrenia, by tracing spontaneous mutations to where and when they likely cause damage in the brain. Some people with the brain disorder may suffer from impaired birth of new neurons, or neurogenesis, in the front of their brain during prenatal development, suggests the study, which was funded by the National Institutes of Health. "Processes critical for the brain's development can be revealed by the mutations that disrupt them," explained Mary-Claire King, Ph.D., University ...

New target for the fight against cancer as a result of excessive blood vessel formation

2013-08-01
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor. To date, the success of these treatments is limited by resistance, poor efficiency and harmful side effects. In the leading scientific journal Cell, Peter Carmeliet (VIB-KU Leuven) and his team reported that sugar metabolism (a process that we call glycolysis) also plays an essential role in the formation of new blood vessels. These totally revolutionary insights open up many new therapeutic ...

'Evolution will punish you if you're selfish and mean'

2013-08-01
EAST LANSING, Mich. — Two Michigan State University evolutionary biologists offer new evidence that evolution doesn't favor the selfish, disproving a theory popularized in 2012. "We found evolution will punish you if you're selfish and mean," said lead author Christoph Adami, MSU professor of microbiology and molecular genetics. "For a short time and against a specific set of opponents, some selfish organisms may come out ahead. But selfishness isn't evolutionarily sustainable." The paper appears in the current issue of Nature Communications and focuses on game theory, ...

New insight into how brain 'learns' cocaine addiction

2013-08-01
A team of researchers says it has solved the longstanding puzzle of why a key protein linked to learning is also needed to become addicted to cocaine. Results of the study, published in the Aug. 1 issue of the journal Cell, describe how the learning-related protein works with other proteins to forge new pathways in the brain in response to a drug-induced rush of the "pleasure" molecule dopamine. By adding important detail to the process of addiction, the researchers, led by a group at Johns Hopkins, say the work may point the way to new treatments. "The broad question ...

Sanford-Burnham researchers map a new metabolic pathway involved in cell growth

2013-08-01
LA JOLLA, Calif., August 1, 2013 — Deciphering the body's complex molecular pathways that lead to disease when they malfunction is highly challenging. Researchers at Sanford-Burnham Medical Research Institute now have a more complete picture of one particular pathway that can lead to cancer and diabetes. In the study published by Molecular Cell, the scientists uncovered how a protein called p62 has a cascade affect in regulating cell growth in response to the presence of nutrients such as amino acids and glucose. Disrupting this chain may offer a new approach to treating ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Ultrasound patch heals venous ulcers in human trial
New technique could significantly accelerate tissue repair, reduce costs for chronic wound management